Recent advances: antiinfectives.
OBJECTIVE
To update readers on the significant changes in infectious diseases pharmacotherapy.


METHODS
An Index Medicus and Iowa Drug Information Service search (1993-1994) of English-language literature pertaining to the selected topic areas was performed. Additional information from abstracts presented at scientific meetings were identified by the authors.


METHODS
All identified studies were screened and those judged relevant to the update were evaluated.


RESULTS
New or clinically significant data since 1992 that related to peptic ulcer disease, microbial resistance (e.g., Enterococcus spp., Streptococcus pneumoniae, Mycobacterium tuberculosis, Candida albicans), immunomodulators, and AIDS were evaluated and compared with previous data.


CONCLUSIONS
There have been several exciting and significant changes in infectious diseases pharmacotherapy evident from this review.
Briceland
L L
LL
Albany College of Pharmacy, NY, USA.
Cleary
J D
JD
Fletcher
C V
CV
Healy
D P
DP
Peloquin
C A
CA
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000998:Antiviral Agents / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy / Q000382:microbiology; D013291:Streptococcus / Q000187:drug effects; D014376:Tuberculosis / Q000188:drug therapy; D015215:Zidovudine / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D015215:Zidovudine